Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kumar Prabhash

Showing results (11-20 of 469) with videos related to

Pageof 47
Sort By:
Journal of Cancer Research and Therapeutics|November 22, 2022
Virtual oncology conferences - The new normal?Anusheel Munshi, Jai Prakash Agarwal, Kumar Prabhash
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2011
Oncology conferences: please call it a dayAnusheel Munshi, Kumar Prabhash, Jai Prakash Agarwal
The European Respiratory Journal|June 2, 2012
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinomaPrasanta Raghab Mohapatra, Sachin Punatar, Kumar Prabhash
Expert Review of Anticancer Therapy|March 12, 2025
A nuanced review of neoadjuvant therapies in oral cancerAkshat Malik, Kanishk Vishnoi, Vanita Noronha, et al.
Cancer Genetics and Cytogenetics|May 14, 2003
Deletion of 6q23 as sole abnormality in acute myelocytic leukemiaT S Sundareshan, Kumar Prabhash, P P Bapsy
Turk Patoloji Dergisi|March 10, 2020
ALK1 Gene Rearranged Pulmonary Sarcomatoid Carcinoma Masquerading as Tuberculosis in a Young MaleAyushi Sahay, Rajiv Kumar, Amit Janu, et al.
The Lancet. Oncology|May 2, 2024
Olanzapine for chemotherapy-induced nausea and vomiting control - Authors' replyJyoti Bajpai, Akash Pawar, Venkatesh Kapu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Palliation in incurable head and neck cancers: chemotherapy?Gouri H Pantvaidya, Anil K D'Cruz, Kumar Prabhash
Indian Journal of Cancer|February 4, 2016
Renal impairment in prostate cancer: A close look is importantVanita Naronha, Rakesh Pinninti, Amit Joshi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 15, 2011
What is the true prevalence of EGFR mutations in India?Sabita Jiwnani, George Karimundackal, C S Pramesh, et al.
Pageof 47

Showing results (11-20 of 469) with videos related to

Sort By:
Pageof 47
Journal of Cancer Research and Therapeutics|November 22, 2022
Virtual oncology conferences - The new normal?Anusheel Munshi, Jai Prakash Agarwal, Kumar Prabhash
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2011
Oncology conferences: please call it a dayAnusheel Munshi, Kumar Prabhash, Jai Prakash Agarwal
The European Respiratory Journal|June 2, 2012
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinomaPrasanta Raghab Mohapatra, Sachin Punatar, Kumar Prabhash
Expert Review of Anticancer Therapy|March 12, 2025
A nuanced review of neoadjuvant therapies in oral cancerAkshat Malik, Kanishk Vishnoi, Vanita Noronha, et al.
Cancer Genetics and Cytogenetics|May 14, 2003
Deletion of 6q23 as sole abnormality in acute myelocytic leukemiaT S Sundareshan, Kumar Prabhash, P P Bapsy
Turk Patoloji Dergisi|March 10, 2020
ALK1 Gene Rearranged Pulmonary Sarcomatoid Carcinoma Masquerading as Tuberculosis in a Young MaleAyushi Sahay, Rajiv Kumar, Amit Janu, et al.
The Lancet. Oncology|May 2, 2024
Olanzapine for chemotherapy-induced nausea and vomiting control - Authors' replyJyoti Bajpai, Akash Pawar, Venkatesh Kapu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Palliation in incurable head and neck cancers: chemotherapy?Gouri H Pantvaidya, Anil K D'Cruz, Kumar Prabhash
Indian Journal of Cancer|February 4, 2016
Renal impairment in prostate cancer: A close look is importantVanita Naronha, Rakesh Pinninti, Amit Joshi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 15, 2011
What is the true prevalence of EGFR mutations in India?Sabita Jiwnani, George Karimundackal, C S Pramesh, et al.
Pageof 47